The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease
Keywords: CAD, coronary artery disease; DBP, diastolic blood pressure; ECG, electrocardiogram; ED, erectile dysfunction; ETT, exercise tolerance test; METS, metabolic equivalents; MI, myocardial infarction; PDE5, phosphodiesterase-5; SBP, systolic blood pressure